LACTOBACILLUS BACTERAEMIA

LACTOBACILLUS BACTERAEMIA was reported 21 times

LACTOBACILLUS BACTERAEMIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Somatostatin Analog [EPC] 4 0.0006
1 Lipid-based Polyene Antifungal [EPC] 4 0.0003
2 SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] 4 0.0003
3 Echinocandin Antifungal [EPC] 2 0.0002
4 Lipopeptide Antibacterial [EPC] 2 0.0002
5 Penem Antibacterial [EPC] 6 0.0002
6 Glycopeptide Antibacterial [EPC] 7 0.0001
7 Polyene Antifungal [EPC] 4 0.0001
8 Fluoroquinolone Antibacterial [EPC] 7 0.0001
9 Vitamin D3 Analog [EPC] 1 0.0000
10 Antimetabolite Immunosuppressant [EPC] 1 0.0000
11 Janus Kinase Inhibitor [EPC] 5 0.0000
12 Calcineurin Inhibitor Immunosuppressant [EPC] 4 0.0000
13 Alkylating Drug [EPC] 5 0.0000
14 Microtubule Inhibitor [EPC] 2 0.0000
15 Histamine-1 Receptor Antagonist [EPC] 1 0.0000
16 Nucleoside Analog Antiviral [EPC] 1 0.0000
17 Nucleoside Metabolic Inhibitor [EPC] 3 0.0000
18 Kinase Inhibitor [EPC] 5 0.0000
19 Proteasome Inhibitor [EPC] 1 0.0000
20 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
21 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
22 Platinum-based Drug [EPC] 2 0.0000
23 Corticosteroid [EPC] 9 0.0000
24 Calcium [EPC] 1 0.0000
25 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
26 Proton Pump Inhibitor [EPC] 2 0.0000
27 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
28 Thalidomide Analog [EPC] 1 0.0000
29 Platelet Aggregation Inhibitor [EPC] 1 0.0000
30 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000